Skip to main content
Premium Trial:

Request an Annual Quote

Neogen Obtains CLIA Certification for Genomics Lab

NEW YORK — Neogen said on Wednesday that its genomics business has received a Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance from the Centers for Medicare & Medicaid Services.

With the CLIA certification, the Lincoln, Nebraska-based business — called Neogen Genomics — may conduct human genotyping, allowing it to perform a range of clinical research projects and high-throughput genetic variant screening, as well as participate in the interrogation of methylation patterns at the genome-wide level for epigenome-wide association studies.

"By earning this CLIA certification, we are able to expand our genomics services into the field of human testing, offering our world-leading services to a variety of new institutions, be involved in new forms of screening, and contribute to research into the human genome," Neogen President and CEO John Adent said in a statement.

Neogen currently offers a range of products and testing services for food and animal safety including DNA sequencing for livestock, diagnostic testing for allergen detection, and sanitation monitoring systems.

In December, the Lansing, Michigan-based company acquired companion animal genetic testing firm Paw Print Genetics. That same month, it signed an agreement to merge its existing operations with 3M's food safety business.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.